CN102276537A - Preparation method of 2-cyan-5-amiopyrimidine - Google Patents

Preparation method of 2-cyan-5-amiopyrimidine Download PDF

Info

Publication number
CN102276537A
CN102276537A CN201110169997A CN201110169997A CN102276537A CN 102276537 A CN102276537 A CN 102276537A CN 201110169997 A CN201110169997 A CN 201110169997A CN 201110169997 A CN201110169997 A CN 201110169997A CN 102276537 A CN102276537 A CN 102276537A
Authority
CN
China
Prior art keywords
pyrimidine
nitro
cyano group
cyan
nitropyrimidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201110169997A
Other languages
Chinese (zh)
Other versions
CN102276537B (en
Inventor
冯丽恒
孙玥
牛伟平
梁飞
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanxi University
Original Assignee
Shanxi University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanxi University filed Critical Shanxi University
Priority to CN 201110169997 priority Critical patent/CN102276537B/en
Publication of CN102276537A publication Critical patent/CN102276537A/en
Application granted granted Critical
Publication of CN102276537B publication Critical patent/CN102276537B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The invention provides a preparation method of 2-cyan-5-amiopyrimidine. The method comprises the following specific steps: nitrifying 2-hydroxypyrimidine hydrochloride serving as a raw material to prepare 2-hydroxyl-5-nitropyrimidine; performing elimination-addition on the 2-hydroxyl-5-nitro-pyrimidine to prepare 2-chloride-5-nitropyrimidine; substituting the 2-chloride-5-nitropyrimidine with cyan to prepare 2-cyan-5-nitropyrimidine; and reducing the 2-cyan-5-nitropyrimidine under illumination to prepare the 2-cyan-5-amiopyrimidine. The synthesis route adopted in the invention is simple (only 4 steps), the raw materials have low price and are easily available, the reaction condition is mild, the intermediate and product are easily separated, and the yield is higher. The prepared 2-cyan-5-amiopyrimidine medical intermediate has wide application prospects in pharmaceutical chemicals, biological anti-cancer and other aspects.

Description

The preparation method of 2-cyano group-5-aminopyrimidine
Technical field
The present invention relates to pyrimidine derivatives, be specifically related to the preparation method of a kind of 2-cyano group-5-aminopyrimidine.
Technical background
Pyrimidines is the very important heterogeneous ring compound of a class, extensively is present in human body and the life entity.Because of the singularity of its structure, that this compounds has is antimycotic, promote the effect of plant growth regulating, can be used for preparing Insecticides (tech) ﹠ Herbicides (tech) and sterilant etc.After itself and metal ion form title complex, not only can prolong activity, lasting period and the transformation period of former medicine, and can reduce mammiferous toxicity.In addition, pyrimidines still is the intermediate of many medicine, agricultural chemicals, and application prospect is boundless.Therefore, it causes people's attention already as new drug molecular designing and the basic building block of synthetic.The situation that hydrogen atom from pyrimidine ring is replaced by different substituents can be divided into single replacement, two replacement, three replacement and four replacements.What obtain easily at present replaces and three replacements for single, and two replacement and quaternary pyrimidine derivatives are less, and especially the pyrimidine compound of 2,5 replacements still less.Correlative study shows that 2-amino or cyano group substituted pyrimidines compound have good antitumor activity, and 5-substituted-amino or cyanopyrimidine compound have stronger antibacterial and anti-inflammation functions.After the pyrimidine ring hydrogen is replaced by amino and cyano group simultaneously, except function, can also modify the amino acid that obtains more pyrimidine derivatives and correspondence by relevant reaction pair active group (amino or cyano group) with single substituted pyrimidines separately.
At present for 2-cyano group-5-aminopyrimidine preparation, Chem.Pharm.Bull.2000,48,1504-1513 and Collection of Czechoslovak Chemical Communications, 1975,40,1396-402 has carried out study on the synthesis to it, and synthetic route is as follows;
Figure BDA0000070393800000011
Said synthesis route needed for 6 steps, and operation is complicated, and especially bad control is reacted in final step, and by product is more.
Summary of the invention
The preparation method who the purpose of this invention is to provide a kind of 2-cyano group-5-aminopyrimidine compounds, this method technology is simple, cost is lower, is easy to realize industrialization.
The preparation method of a kind of 2-cyano group provided by the invention-5-aminopyrimidine comprises the steps:
1), preparation 2-chloro-5-nitro-pyrimidine, can be according to existing document (Patent:WO2007/135350; (2007)) preparation;
Figure BDA0000070393800000021
2), the DMSO solution that will be dissolved with 2-chloro-5-nitro-pyrimidine splashes among the DMSO and water mixed solvent that contains NaCN and DABCO, stirred overnight at room temperature, reaction solution is used 1mol/L hydrochloric acid, saturated NaHCO successively through ethyl acetate extraction 3, the saturated common salt water washing, drying is revolved to desolventize and is obtained 2-cyano group-5 nitro-pyrimidine; Reaction equation is as follows:
3), under the nitrogen protection, in the acetonitrile solvent, 2-cyano group-5-nitro-pyrimidine and formic acid are reacted 1.5-2.5h under λ=254nm rayed, add less water and solid Na 2CO 3, stirring, extracted with diethyl ether is separated, and ether-hexanaphthene recrystallization obtains 2-cyano group-5-aminopyrimidine; Reaction equation is as follows:
Figure BDA0000070393800000023
Step 2) in, the mol ratio of described 2-chloro-5-nitro-pyrimidine, DABCO and NaCN is 7~10: 1: 7~15; Described DMSO and H 2The volume ratio of O is 2-4: 1;
In the step 3), described H 2O and CH 3The CN volume ratio is 1: 3~6,2-cyano group-5-nitro-pyrimidine, formic acid and Na 2CO 3Mol ratio is 1: 10-15: 15-30;
Advantage compared with prior art of the present invention and effect:
Synthetic route of the present invention simple (only 4 steps), raw material cheaply is easy to get, the reaction conditions gentleness, intermediate and product are easily separated, and productive rate is higher.The 2-cyano group for preparing-5-aminopyrimidine medicine intermediate has broad application prospects at aspects such as medication chemistry and biological anticancers.
Embodiment
Embodiment 1
1) in the there-necked flask of the 500mL that electric mixer is housed, add the 200mL vitriol oil, the ice bath cooling is also stirred down, and 25.92g (0.20mol) 2-hydroxy pyrimidine hydrochloride is added in the sulphuric acid soln in batches.By constant pressure funnel 65.0g (0.40mol) nitrosonitric acid is splashed into then, be heated to 90 ℃ of stirring reaction 24h.Reaction is poured in a large amount of frozen water after finishing to be cooled to room temperature, the pH=2.5 that neutralizes of the sodium hydroxide solution with 50%.(3 * 300mL) extractions three times merge organic phase, with saturated common salt water washing (2 * 300mL) washed twice with ethyl acetate, anhydrous sodium sulfate drying, decompression is revolved to desolventize and is obtained thick product 2-hydroxyl-5-nitro-pyrimidine 11.5g, and productive rate 42.2% does not need directly next step reaction of purifying.
In the 250mL there-necked flask of magnetic stirring apparatus is housed, add 10.0g (0.071mol) 2-hydroxyl-5-nitro-pyrimidine, 9.0mL (0.071mol) N after accelerine and the 100mL phosphorus oxychloride, adds back flow reaction, and the TLC detection reaction finishes.After most of phosphorus oxychloride is removed in underpressure distillation, pour into and stir 30min in the frozen water.(3 * 150mL) extractions three times merge organic phase, and behind anhydrous sodium sulfate drying, decompression is revolved to desolventize and obtained thick product, get product, 2-chloro-5-nitro-pyrimidine 6.29g, productive rate: 55.6% behind the recrystallization with methylene dichloride. 1H?NMR(CDCl 3/400MHz)δ9.38(s,2H); 13C?NMR(CDCl 3/100MHz)δ141.2,153.8,165.9;EI-MS(m/z)158.63[M +],160.58[M ++2]。
2) in the there-necked flask of the 250mL that magnetic stirring apparatus is housed, add 1.715g (0.035mol) sodium cyanide, 0.54g (5.0mmol) DABCO, 15mL DMSO and 30mL water.The 20mL DMSO solution that will be dissolved with 5.58g (0.035mol) 2-chloro-5-nitro-pyrimidine then splashes in the above-mentioned solution.Reaction mixture at room temperature stirs and spends the night, reaction solution is poured in the 250mL water, with ethyl acetate extraction three times (3 * 150mL), merge organic phase, after washing with 1N hydrochloric acid, saturated sodium bicarbonate solution and saturated nacl aqueous solution successively, anhydrous sodium sulfate drying, decompression is revolved to desolventize and is obtained white solid, 2-cyano group-5-nitro-pyrimidine 4.73g, productive rate: 90.3%. 1H?NMR(CDCl 3/400MHz)δ9.96(s,2H); 13C?NMR(CDCl 3/100MHz)δ111.2,144.8,151.2,152.9;EI-MS(m/z)151.05[M ++1]。
3) under nitrogen protection, 3.0g in the 100mL there-necked flask (0.02mol) 2-cyano group-5-nitro-pyrimidine adds 10 times of normal formic acid, the 40mL acetonitrile that outgases.Under the rayed of 254nm, stirring reaction 2h.After reaction finishes, in mixing also, add 10ml water and excessive N a 2CO 3Solid, after stirring 10min, filter, decompression is used extracted with diethyl ether 3 times (3 * 150mL) after revolving and removing a large amount of solvents, merge organic phase, anhydrous sodium sulfate drying, the crude product that desolventizes is revolved in decompression, and crude product gets white solid through ether-normal hexane recrystallization, 2-cyano group-5-aminopyrimidine 2.12g, productive rate 88.45%. 1H?NMR(CDCl 3/400MHz)δ4.08(s,2H),8.81(s,2H); 13C?NMR(CDCl 3/100MHz)δ110.9,133.6,145.8,149.2;EI-MS(m/z)121.03[M ++1]。
Embodiment 2
1) with embodiment 1
2) in the there-necked flask of the 250mL that magnetic stirring apparatus is housed, add 2.45g (0.05mol) sodium cyanide, 0.45g (4.17mmol) DABCO, 20mL DMSO and 30mL water.The 20mL DMSO solution that will be dissolved with 5.58g (0.035mol) 2-chloro-5-nitro-pyrimidine then splashes in the above-mentioned solution.Reaction mixture at room temperature stirs and spends the night, reaction solution is poured in the 250mL water, with ethyl acetate extraction three times (3 * 150mL), merge organic phase, after washing with 1N hydrochloric acid, saturated sodium bicarbonate solution and saturated nacl aqueous solution successively, anhydrous sodium sulfate drying, decompression is revolved to desolventize and is obtained white solid, 2-cyano group-5-nitro-pyrimidine 4.82g, productive rate: 92.1%. 1H?NMR(CDCl 3/400MHz)δ9.96(s,2H); 13C?NMR(CDCl 3/100MHz)δ111.2,144.8,151.2,152.9;EI-MS(m/z)151.05[M ++1]。
3) under nitrogen protection, 3.0g in the 100mL there-necked flask (0.02mol) 2-cyano group-5-nitro-pyrimidine adds 15 times of normal formic acid, the 40mL acetonitrile that outgases.Under the rayed of 254nm, stirring reaction 2.0h.After reaction finishes, in mixing also, add 10ml water and excessive N a 2CO 3Solid, after stirring 10min, filter, decompression is used extracted with diethyl ether 3 times (3 * 150mL) after revolving and removing a large amount of solvents, merge organic phase, anhydrous sodium sulfate drying, the crude product that desolventizes is revolved in decompression, and crude product gets white solid through ether-normal hexane recrystallization, 2-cyano group-5-aminopyrimidine 2.11g, productive rate 87.48%. 1H?NMR(CDCl 3/400MHz)δ4.11(s,2H),8.87(s,2H); 13C?NMR(CDCl 3/100MHz)δ111.7,133.4,145.9,150.9;EI-MS(m/z)121.22[M ++1]。
Embodiment 3
1) with embodiment 1
2) with embodiment 1
3) under nitrogen protection, 3.0g in the 100mL there-necked flask (0.02mol) 2-cyano group-5-nitro-pyrimidine adds 12 times of normal formic acid, the 40mL acetonitrile that outgases.Under the rayed of 254nm, stirring reaction 1.5h.After reaction finishes, in mixing also, add 10ml water and excessive N a 2CO 3Solid, after stirring 10min, filter, decompression is used extracted with diethyl ether 3 times (3 * 150mL) after revolving and removing a large amount of solvents, merge organic phase, anhydrous sodium sulfate drying, the crude product that desolventizes is revolved in decompression, and crude product gets white solid through ether-normal hexane recrystallization, 2-cyano group-5-aminopyrimidine 2.05g, productive rate 85.37%. 1H?NMR(CDCl 3/400MHz)δ4.09(s,2H),8.85(s,2H); 13C?NMR(CDCl 3/100MHz)δ111.3,133.1,145.7,150.1;EI-MS(m/z)121.43[M ++1]。

Claims (1)

1. the preparation method of 2-cyano group-5-aminopyrimidine is characterized in that, comprises the steps:
1), preparation 2-chloro-5-nitro-pyrimidine;
2), the DMSO solution that will be dissolved with 2-chloro-5-nitro-pyrimidine splashes among the DMSO and water mixed solvent that contains NaCN and DABCO, stirred overnight at room temperature, reaction solution is used 1mol/L hydrochloric acid, saturated NaHCO successively through ethyl acetate extraction 3, the saturated common salt water washing, drying is revolved to desolventize and is obtained 2-cyano group-5 nitro-pyrimidine; Reaction equation is as follows:
Figure FDA0000070393790000011
3), under the nitrogen protection, in the acetonitrile solvent, 2-cyano group-5-nitro-pyrimidine and formic acid are reacted 1.5-2.5h under λ=254nm rayed, add less water and solid Na 2CO 3, stirring, extracted with diethyl ether is separated, and ether-hexanaphthene recrystallization obtains 2-cyano group-5-aminopyrimidine; Reaction equation is as follows:
Figure FDA0000070393790000012
Step 2) in, the mol ratio of described 2-chloro-5-nitro-pyrimidine, DABCO and NaCN is 7~10: 1: 7~15; Described DMSO and H 2The volume ratio of O is 2-4: 1;
In the step 3), described H 2O and CH 3The CN volume ratio is 1: 3~6,2-cyano group-5-nitro-pyrimidine, formic acid and Na 2CO 3Mol ratio is 1: 10-15: 15-30.
CN 201110169997 2011-06-22 2011-06-22 Preparation method of 2-cyan-5-amiopyrimidine Expired - Fee Related CN102276537B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 201110169997 CN102276537B (en) 2011-06-22 2011-06-22 Preparation method of 2-cyan-5-amiopyrimidine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 201110169997 CN102276537B (en) 2011-06-22 2011-06-22 Preparation method of 2-cyan-5-amiopyrimidine

Publications (2)

Publication Number Publication Date
CN102276537A true CN102276537A (en) 2011-12-14
CN102276537B CN102276537B (en) 2013-01-23

Family

ID=45102325

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 201110169997 Expired - Fee Related CN102276537B (en) 2011-06-22 2011-06-22 Preparation method of 2-cyan-5-amiopyrimidine

Country Status (1)

Country Link
CN (1) CN102276537B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105693707A (en) * 2016-04-05 2016-06-22 叶芳 4-bissulfurylamidino substituted pyrimidine compounds and preparation method thereof
CN115772127A (en) * 2023-01-31 2023-03-10 山东佰隆医药有限公司 Method for synthesizing 2-cyano-5-bromopyrimidine

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101219997A (en) * 2008-01-02 2008-07-16 苏州博鸿化工技术有限公司 Synthesis of 2-chlorine-5- amido pyrimidine

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101219997A (en) * 2008-01-02 2008-07-16 苏州博鸿化工技术有限公司 Synthesis of 2-chlorine-5- amido pyrimidine

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
KIMINORI OHTA: "Retinoidal Pyrimidinecarboxylic Acid.Unexpected Diaza-Substituent Effect in Retinobenzoic Acid", 《CHEM.PHARM.BULL》, 31 December 2000 (2000-12-31), pages 1504 - 1513 *
M.A.MIKHALLEVA: "Synthesis of Schiff bases of 2-substituted 5-aminopyrimidines and their mesomorphic properties", 《CHEMISTRY OF HETEROCYCLIC COMPOUNDS》, vol. 18, no. 11, 31 December 1982 (1982-12-31), pages 1201 - 1208 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105693707A (en) * 2016-04-05 2016-06-22 叶芳 4-bissulfurylamidino substituted pyrimidine compounds and preparation method thereof
CN115772127A (en) * 2023-01-31 2023-03-10 山东佰隆医药有限公司 Method for synthesizing 2-cyano-5-bromopyrimidine

Also Published As

Publication number Publication date
CN102276537B (en) 2013-01-23

Similar Documents

Publication Publication Date Title
CN106279074B (en) A kind of compound and preparation method thereof and the purposes in Bu Waxitan is synthesized
CN106365986B (en) Compound and preparation method thereof and the purposes in synthesis Bu Waxitan
CN107311875A (en) The synthetic method of aramine
CN103601686A (en) Method for synthesizing fluorine-containing pyrimidine compounds by virtue of one-pot method
CN103087019B (en) Preparation method of tasimelteon
CN102276537B (en) Preparation method of 2-cyan-5-amiopyrimidine
CN102260210B (en) Preparation method of naphthoyl amine derivatives of protein kinase inhibitor and histone deacetylase inhibitor
CN102001979A (en) Preparation method of 2-(2', 2'-difluoroethoxyl)-6-trifluoromethyl phenyl propyl sulfide
CN104610267B (en) Method for efficiently synthesizing 6-alkyl pyrazolo [1,5-c ] quinazoline framework compound under non-catalytic condition
CN105820174A (en) Polysubstituted thienoindole derivative and preparation method thereof
CN110407841A (en) A kind of synthetic method of anti-tumor drug Rui Boxini
CN103113177B (en) Preparation method of amide
CN102911123B (en) Preparation method of 2-chloro trifluoromethyl pyrimidine compound
CN103145666B (en) 4-substituted alpha-pyrone derivative as well as preparation method and application thereof
CN101921225B (en) Pirfenidone compound, preparation method and application thereof
CN104592230B (en) 2-(granatane3-amino)-4-tetrahydronaphthalene indazole-substituted benzamide compound and application thereof
CN104119302B (en) Chiral tetrahydrofuran compound as well as preparation method and dehydration product thereof
CN104693071A (en) N-hydroxyl-N'-benzyl octanediamide preparation method
CN102827060B (en) Synthetic method of 5-trifluoromethyl pyrrole-2-formic acid
CN102827019A (en) One group of novel benzene cyclobutane compounds and application of novel benzene cyclobutane compounds in chemical synthesis
CN104817482A (en) 2-substituted pyrrolidine compound, preparation method and application thereof in preparation of vildagliptin
CN109574856A (en) A kind of new Rimantadine analog and its synthetic method
CN103193679A (en) Preparation method of rivastigmine intermediate (R)-N-ethyl-N-methyl carbamic acid-3-(1-hydroxyethyl) phenyl ester
CN104211701A (en) Method for preparing moxifloxacin impurities B and D
CN102093294A (en) Method for preparing 7-chlorine-5-hydroxy-2,3,4,5-tetrahydrogen-1H-1-benzodiazepine

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20130123

Termination date: 20150622

EXPY Termination of patent right or utility model